Acute Myeloid Leukemia — Fifth Annual National General Medical Oncology Summit
About this episode
This episode features discussions on current management approaches and future treatment options for Acute Myeloid Leukemia.
Featuring perspectives from Dr Courtney D DiNardo and Dr Harry Paul Erba, including the following topics: Introduction (0:00) Current Management Approaches for FLT3- and IDH-Mutated Acute Myeloid Leukemia (AML) — Dr DiNardo (9:44) Current and Future Role of Menin Inhibitors for Patients with AML — Dr Erba (32:07) CME information and select publications
More episodes of Hematologic Oncology Update
- For Oncology Nurses: Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia — Proceedings from the 2026 Annual ONS Congress
- Novel Therapies for Non-Hodgkin Lymphoma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
- Myelofibrosis and Systemic Mastocytosis — Fifth Annual National General Medical Oncology Summit
- Multiple Myeloma — Fifth Annual National General Medical Oncology Summit
- Chronic Lymphocytic Leukemia — Fifth Annual National General Medical Oncology Summit
- Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Fifth Annual National General Medical Oncology Summit
Explore listener stats, chart rankings, contacts and more on the Hematologic Oncology Update podcast page.